OXFORD BIOMEDICA LS-50/ GB00BDFBVT43 /
| 9/20/2024 7:57:06 AM | Chg. +0.1600 | Volume | Bid9/20/2024 | Ask9/20/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.2600EUR | +3.90% | - Turnover: - |
4.0800Bid Size: 250 | 4.4400Ask Size: 250 | 334.64 mill.EUR | - | - |
Fundamentals
| FY 2020 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.08 GBP | -64.98 |
| EPS Diluted: | 0.08 GBP | - |
| Revenues per Share: | 1.10 GBP | 24.44% |
| Book Value per Share: | 1.41 GBP | 35.58% |
| Cash Flow per Share: | 0.04 GBP | - |
| Dividend per Share: | 0.00 GBP | - |
| Total | in mill. | |
| Revenues: | 87.70 GBP | 36.82% |
| Net Income: | -6.20 GBP | -61.49% |
| Operating Cash Flow: | 3.10 GBP | - |
| Cash and Cash Equivalents: | 46.70 GBP | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 45.09 | 129.32 |
| P/S Ratio: | 3.21 | 9.21 |
| P/BV ratio: | 2.50 | 7.16 |
| P/CF Ratio: | 90.81 | 260.47 |
| PEG: | - | - |
| Earnings Yield: | 2.22% | 0.77% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 334.64 mill. EUR | 905.95 mill. EUR |
| Free Float Market Cap.: | 167.99 mill. EUR | 454.79 mill. EUR |
| Market Cap. / Employee: | 497,236.1989 EUR | 1.35 mill. EUR |
| Shares Outstanding: | 79.95 mill. | |
Profitability
| Gross Profit Margin: | 52.57% |
| EBIT Margin: | -6.50% |
| Net Profit Margin: | -7.07% |
| Return on Equity: | -5.50% |
| Return on Assets: | -3.37% |
Financial Strength
| Liquidity I / Cash Ratio: | 88.95% |
| Liquidity II / Quick Ratio: | 191.62% |
| Liquidity III / Current Ratio: | 205.52% |
| Debt / Equity Ratio: | 63.18% |
| Dynam. Debt / Equity Ratio: | 2,296.77% |
Efficiency
| Employees: | 673 |
| Personal Expenses / Employee: | - GBP |
| Revenues / Employee: | 130,312.04 GBP |
| Net Income / Employee: | -9,212.48 GBP |
| Total Assets / Employee: | 273,254.09 GBP |
| * Fiscal Year End: | 12/31/2020 |
| Accounting Standard: | IFRS |
| Currency: | GBP |
